BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Abilita Bio Changes Name to Abilita Therapeutics and Appoints Joel Edwards as Chief Business Officer

  Abilita Bio, a leader in enabling the discovery of membrane protein-targeted therapeutics, announced today the company changed its name to Abilita Therapeutics.

  June 1, 2023

   · 

  3 min read
• Pharm Country

  Bristol Myers Squibb to Participate in Upcoming Investor Conferences

  Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the following investor conferences in June 2023.

  June 1, 2023

   · 

  1 min read
• Biotech Bay

  Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference

  Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference being held from June 7-9, 2023 in New York.

  June 1, 2023

   · 

  1 min read
• Pharm Country

  MindMed to Participate at Upcoming Investor Conferences

  Mind Medicine announced today that members of the Company’s management team will participate in the following investor conferences.

  June 1, 2023

   · 

  1 min read
• Business

  Can-Fite Reports First Quarter 2023 Financial Results & Provides Clinical Update

  Can-Fite BioPharma Ltd today announced financial results for the three months ended March 31, 2023.

  June 1, 2023

   · 

  13 min read
• BioMidwest

  Xeris Biopharma to Participate at the Jefferies Healthcare Conference

  Xeris Biopharma Holdings, Inc. today announced that members of its senior management will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 8 at 10:30am Eastern Time.

  June 1, 2023

   · 

  1 min read
• BioMidwest

  Abeona Therapeutics to Present at the Jefferies Healthcare Conference - June 1, 2023

  Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9, 2023 at 9:00 a.m. Eastern time.

  June 1, 2023

   · 

  2 min read
• Drug Development

  Aviceda Announces Dosing of First Patient With AVD-104, a Novel Glyco-Mimetic Nanoparticle for the Treatment of Geographic Atrophy from Macular Degeneration, in the Phase 2 SIGLEC Trial

  Aviceda Therapeutics announced the dosing of its first patient with AVD-104 in its Phase 2 SIGLEC Trial today by Ashkan Abbey, MD of Texas Retina Associates in Dallas.

  June 1, 2023

   · 

  4 min read
• Drug Development

  IAMA Therapeutics to Present at Upcoming BIO International Convention

  IAMA Therapeutics today announced that Andrea Malizia, Chief Executive Officer, will present at the BIO International Convention, taking place June 5-8, 2023, in Boston, MA.

  June 1, 2023

   · 

  1 min read
• Cybin to Present at the Jefferies Healthcare Conference

  Cybin Inc. is pleased to announce that Doug Drysdale, Cybin’s Chief Executive Officer, will present at the Jefferies Healthcare Conference taking place in New York City, NY from June 7-9, 2023.

  June 1, 2023

   · 

  1 min read